Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study

被引：0

作者：

Lucheng ZHU

Changlin Zou

Zhanchun Zhang

Jianfang Wang

Li Yang

Chuangzhou Rao

Zhiping Yang

Jiafeng Liang

Bing Xia

M. A. Shenglin

机构：

[1] Affiliated Hangzhou Cancer Hospital,Department of Thoracic Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province

[2] Zhejiang University School of Medicine,Department of Radiotherapy

[3] The First Affiliated Hospital of Wenzhou Medical University,Department of Radiotherapy

[4] Ningbo Medical Center Lihuili Hospital,Department of Radiotherapy, Shaoxing People’s Hospital (Shaoxing Hospital

[5] Zhejiang University School of Medicine),Department of Pulmonary & Critical Care Medicine, Shulan (Hangzhou) Hospital

[6] Affiliated to Zhejiang Shuren University Shulan International Medical college,Department of Radiotherapy & Chemotherapy,Hwa Mei Hospital

[7] University of Chinese Academy of Sciences,Department of Oncology, Affiliated Hospital of Jiaxing University

[8] The First Hospital of Jiaxing,Department of Oncology

[9] Jiande Second People’s Hospital,Department of Cancer Medical Center

[10] Affiliated Xiaoshan Hospital,undefined

[11] Hangzhou Normal University,undefined

来源：

BMC Cancer | / 21卷

关键词：

Almonertinib; EGFR-TKI; Radiotherapy; Locally advanced NSCLC; Radiation pneumonitis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer [J].

Zhang, N. ;

Gao, Y. ;

Zeng, Z. ;

Luo, Y. ;

Jiang, X. ;

Zhang, J. ;

Li, J. ;

Gong, Y. ;

Xie, C. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (09) :1827-1837

[32] RADIOTHERAPY VERSUS RADIOTHERAPY ENHANCED BY CISPLATIN IN STAGE-III NON-SMALL-CELL LUNG-CANCER [J].

TROVO, MG ;

MINATEL, E ;

FRANCHIN, G ;

BOCCIERI, MG ;

NASCIMBEN, O ;

BOLZICCO, G ;

PIZZI, G ;

TORRETTA, A ;

VERONESI, A ;

GOBITTI, C ;

ZANELLI, DJ ;

MONFARDINI, S .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (01) :11-15

[33] PACIFIC-9: Phase III trial of durvalumab plus oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer [J].

Barlesi, Fabrice ;

Cho, Byoung Chul ;

Goldberg, Sarah B. ;

Yoh, Kiyotaka ;

Gelatti, Ana Caroline Zimmer ;

Mann, Helen ;

Gopinathan, Aarthi ;

Bielecka, Zofia Felicja ;

Newton, Michael ;

Aggarwal, Charu .

FUTURE ONCOLOGY, 2024, 20 (29) :2137-2147

[34] Dose-Escalation Study of Three-Dimensional Conformal Thoracic Radiotherapy With Concurrent S-1 and Cisplatin for Inoperable Stage III Non-Small-Cell Lung Cancer [J].

Harada, Hideyuki ;

Nishio, Makoto ;

Murakami, Haruyasu ;

Ohyanagi, Fumiyoshi ;

Kozuka, Takuyo ;

Ishikura, Satoshi ;

Naito, Tateaki ;

Kaira, Kyoichi ;

Takahashi, Toshiaki ;

Horiike, Atsushi ;

Nishimura, Tetsuo ;

Yamamoto, Nobuyuki .

CLINICAL LUNG CANCER, 2013, 14 (04) :440-445

[35] Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity [J].

Phernambucq, E. C. J. ;

Spoelstra, F. O. B. ;

Verbakel, W. F. A. R. ;

Postmus, P. E. ;

Melissant, C. F. ;

van den Brink, K. I. Maassen ;

Frings, V. ;

van de Ven, P. M. ;

Smit, E. F. ;

Senan, S. .

ANNALS OF ONCOLOGY, 2011, 22 (01) :132-138

[36] Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches [J].

Cortiula, F. ;

Reymen, B. ;

Peters, S. ;

Van Mol, P. ;

Wauters, E. ;

Vansteenkiste, J. ;

De Ruysscher, D. ;

Hendriks, L. E. L. .

ANNALS OF ONCOLOGY, 2022, 33 (09) :893-908

[37] Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients [J].

Yin, Hanjing ;

Jia, Wenxiao ;

Yu, Jinming ;

Zhu, Hui .

BMC CANCER, 2024, 24 (01)

[38] Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients [J].

Hanjing Yin ;

Wenxiao Jia ;

Jinming Yu ;

Hui Zhu .

BMC Cancer, 24

[39] Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer [J].

Bobbili, Priyanka ;

Ryan, Kellie ;

Duh, Mei S. ;

Dua, Akanksha ;

Fernandes, Ancilla W. ;

Pavilack, Melissa ;

Gomez, Jorge E. .

FUTURE ONCOLOGY, 2019, 15 (29) :3381-3393

[40] A Phase I Study of Temsirolimus and Thoracic Radiation in Non-Small-Cell Lung Cancer [J].

Waqar, Saiama N. ;

Robinson, Clifford ;

Bradley, Jeffrey ;

Goodgame, Boone ;

Rooney, Melissa ;

Williams, Kristina ;

Gao, Feng ;

Govindan, Ramaswamy .

CLINICAL LUNG CANCER, 2014, 15 (02) :119-123

← 1 2 3 4 5 →